ENSYSCE BIOSCIENCES INC (ENSC) Stock Earnings & Estimates
NASDAQ:ENSC - US2936025046 - Common Stock
2.135 USD
-0.02 (-0.7%)
2.15 USD
+0.02 (+0.7%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 2.52M -28.61% | 2.231M -11.49% | 5.21M 133.58% | 2.805M -46.16% | 40.8M 1,354.55% | 89.062M 118.29% | |
| EBITDA YoY % growth | -24.23M -21.94% | N/A 54.32% | N/A -81.50% | -22.748M -13.24% | -11.836M 47.97% | 10.687M 190.29% | |
| EBIT YoY % growth | -24.23M -21.94% | -10.718M 55.76% | -6.73M 37.21% | -13.397M -99.06% | -15.546M -16.04% | 10.251M 165.94% | |
| Operating Margin | -961.51% | -480.53% | -129.18% | -477.60% | -38.10% | 11.51% | |
| EPS YoY % growth | -1,486.80 52.64% | -79.50 94.65% | -13.40 83.14% | -4.28 68.03% | -0.03 99.29% | N/A |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.88 -184.03% | -0.69 76.26% | -0.84 39.83% | -0.44 44.48% | -0.36 59.54% | -0.60 12.59% |
| Revenue Q2Q % growth | 714K -79.12% | 714K -45.25% | -100.00% | -100.00% | -100.00% | -100.00% |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -0.79 76.06% | -1.20 | 0.41 | 34.36% |
| Q1 2025 Q2Q % growth | -1.39 83.15% | -3.08 | 1.69 | 54.80% |
| Q4 2024 Q2Q % growth | -2.90 85.89% | -2.79 | -0.11 | -3.95% |
| Q3 2024 Q2Q % growth | 1.05 108.05% | -4.51 | 5.56 | 123.26% |
| Q2 2024 Q2Q % growth | -3.30 77.55% | -5.97 | 2.67 | 44.70% |
| Q1 2024 Q2Q % growth | -8.25 73.56% | -13.77 | 5.52 | 40.09% |
| Q4 2023 Q2Q % growth | -20.55 92.49% | -13.31 | -7.24 | -54.38% |
| Q3 2023 Q2Q % growth | -13.05 90.20% | -16.17 | 3.12 | 19.28% |
| Q2 2023 Q2Q % growth | -14.70 98.30% | -41.72 | 27.02 | 64.76% |
| Q1 2023 Q2Q % growth | -31.20 85.56% | -77.67 | 46.47 | 59.83% |
| Q4 2022 Q2Q % growth | -273.60 83.11% | -441.86 | 168.26 | 38.08% |
| Q3 2022 Q2Q % growth | -133.20 -18,660.56% | -587.52 | 454.32 | 77.33% |
| Q2 2022 Q2Q % growth | -864.00 | -624.24 | -239.76 | -38.41% |
| Q1 2022 Q2Q % growth | -216.00 | -587.52 | 371.52 | 63.24% |
| Q4 2021 Q2Q % growth | -1,620.00 | -73.44 | -1,546.56 | -2,105.88% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 1.371M 654.13% | 663K | 708K | 106.79% |
| Q1 2025 Q2Q % growth | 1.32M 331.69% | 1.32M | % | |
| Q4 2024 Q2Q % growth | 1.304M 153.19% | 255K | 1.049M | 411.37% |
| Q3 2024 Q2Q % growth | 3.419M 685.29% | 255K | 3.164M | 1,240.78% |
| Q2 2024 Q2Q % growth | 181.8K -62.90% | 306K | -124.2K | -40.59% |
| Q1 2024 Q2Q % growth | 305.72K -61.30% | 408K | -102.28K | -25.07% |
| Q4 2023 Q2Q % growth | 515.03K -63.98% | 402.9K | 112.13K | 27.83% |
| Q3 2023 Q2Q % growth | 435.38K 55.49% | 605.197K | -169.817K | -28.06% |
| Q2 2023 Q2Q % growth | 490K 133.33% | 843.203K | -353.203K | -41.89% |
| Q1 2023 Q2Q % growth | 790K 31.67% | 969K | -179K | -18.47% |
| Q4 2022 Q2Q % growth | 1.43M -12.80% | 1.571M | -141K | -8.98% |
| Q3 2022 Q2Q % growth | 280K -76.67% | 1.02M | -740K | -72.55% |
| Q2 2022 Q2Q % growth | 210K -52.27% | 1.02M | -810K | -79.41% |
| Q1 2022 Q2Q % growth | 600K 140.00% | 1.224M | -624K | -50.98% |
| Q4 2021 Q2Q % growth | 1.64M | 1.02M | 620K | 60.78% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 61.37% | -1.45% | 56.99% |
| Revenue | 0% | 0% | 1.85% | 1.85% |